IFEANULI ONA: Open Payments
NPI 1457044836 · MORRIS PLAINS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,614 in 92 payments from 13 companies in 2025. Trend: 2023 $762 · 2024 $1,495 · 2025 $1,614
Food & beverage: $1,614
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $275 |
| Janssen Pharmaceuticals, Inc | 13 | $224 |
| Braeburn Inc. | 14 | $208 |
| E.R. Squibb & Sons, L.L.C. | 15 | $200 |
| Otsuka America Pharmaceutical, Inc. | 4 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $147 |
| Alkermes, Inc. | 5 | $104 |
| Teva Pharmaceuticals USA, Inc. | 5 | $83 |
| Vanda Pharmaceuticals Inc. | 4 | $63 |
| Indivior Inc. | 4 | $60 |
Products named: VRAYLAR, INVEGA SUSTENNA, BRIXADI, COBENFY, REXULTI, CAPLYTA, ARISTADA, UZEDY.
Industry payments across NJ — which companies pay providers there.
